Muenster; Uwe

Patent Applications and Registrations

Patent applications and USPTO patent grants for Muenster; Uwe.The latest application filed is for "substituted n-arylethyl-2-arylquinoline-4-carboxamides and use thereof".

Company Profile

4.5.16

Muenster; Uwe - Wuppertal DE
Muenster; Uwe - Wulfrath DE
Muenster; Uwe - Berlin DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted N-arylethyl-2-arylquinoline-4-carboxamides and use thereof Grant 11,136,296 - Beck , et al. October 5, 2	2021-10-05
Substituted N-arylethyl-2-arylquinoline-4-carboxamides And Use Thereof App 20200031775 - BECK; Hartmut ; et al.	2020-01-30
Substituted N,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agents Grant 10,479,765 - Beck , et al. Nov	2019-11-19
Substituted N,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agents Grant 10,189,788 - Beck , et al. Ja	2019-01-29
Substituted N,2-diarylquinoline-4-carboxamides And The Use Thereof As Anti-inflammatory Agents App 20190002409 - BECK; Hartmut ; et al.	2019-01-03
Substituted N-bicyclo-2-aryl-quinolin-4-carboxamides and use thereof Grant 10,117,864 - Beck , et al. November 6, 2	2018-11-06
Process For The Preparation Of Porous Microparticles App 20180169019 - MUENSTER; Uwe ; et al.	2018-06-21
Substituted N-bicyclo-2-aryl-quinolin-4-carboxamides And Use Thereof App 20180036300 - BECK; Hartmut ; et al.	2018-02-08
Substituted N,2-diarylquinoline-4-carboxamides And The Use Thereof As Anti-inflammatory Agents App 20170260140 - BECK; Hartmut ; et al.	2017-09-14
Topical Ophthalmological Pharmaceutical Composition Containing Regorafenib App 20150328145 - BOTTGER; Michael ; et al.	2015-11-19
Topical Ophthalmological Pharmaceutical Composition Containing Sunitinib App 20150174096 - Bottger; Michael ; et al.	2015-06-25
Topical Ophthalmological Pharmaceutical Composition Containing Cediranib App 20150165028 - Bottger; Michael ; et al.	2015-06-18
Topical Ophthalmological Pharmaceutical Composition containing Axitinib App 20150164790 - Bottger; Michael ; et al.	2015-06-18
Topical Ophthalmological Pharmaceutical Composition containing Pazopanib App 20150141448 - Bottger; Michael ; et al.	2015-05-21
Topical Ophthalmological Pharmaceutical Composition Containing Regoragenib App 20140296301 - Bottger; Michael ; et al.	2014-10-02
Topical Ophthalmological Pharmaceutical Composition containing Sorafenib App 20140235678 - Bottger; Michael ; et al.	2014-08-21
Topical Ophthalmological Pharmaceutical Composition Containing Regorafenib App 20140179745 - BOTTGER; Michael ; et al.	2014-06-26
Preparations for topical administration of substances having antiandrogenic activity Grant 6,875,438 - Kraemer , et al. April 5, 2	2005-04-05
Preparations for topical administration of substances having antiandrogenic activity App 20030229129 - Kraemer, Karl Theodor ; et al.	2003-12-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.